Life (Oct 2021)

Cardiac Transplantation and the Use of Cannabis

  • Hirak Shah,
  • Meg Fraser,
  • Arianne C. Agdamag,
  • Valmiki Maharaj,
  • Bellony Nzemenoh,
  • Cindy M. Martin,
  • Tamas Alexy,
  • Daniel J. Garry

DOI
https://doi.org/10.3390/life11101063
Journal volume & issue
Vol. 11, no. 10
p. 1063

Abstract

Read online

Cardiac transplantation requires the careful allocation of a limited number of precious organs. Therefore, it is critical to select candidates that will receive the greatest anticipated medical benefit but will also serve as the best stewards of the organ. Individual transplant teams have established prerequisites pertaining to recreational drug, tobacco, alcohol, and controlled substance use in potential organ recipients and post-transplantation. Legalization of cannabis and implementation of its prescription-based use for the management of patients with chronic conditions have been increasing over the past years. Center requirements regarding abstinence from recreational and medical cannabis use vary due to rapidly changing state regulations, as well as the lack of clinical safety data in this population. This is evident by the results of the multicenter survey presented in this paper. Developing uniform guidelines around cannabis use will be imperative not only for providers but also for patients.

Keywords